A dose-by-dose breakdown of what Mounjaro (tirzepatide) actually costs each month in India, plus dosage, side effects, and safety information you need before you start.
For many people considering Mounjaro in India, the first question is simple, what will it cost each month. Almost everyone managing type 2 diabetes or their weight asks this before starting.
This guide gives a clear price breakdown by dose for 2026, along with how the medicine works, side effects, and the full monthly cost once tests and consultations are added in.
Quick Answer
- The listed cost for four weekly doses of Mounjaro ranges from about ₹13,125 to ₹25,781, depending on strength and pack.
- The 2.5 mg starting dose costs about ₹13,125 for a month. The highest 15 mg dose costs about ₹25,781.
- It is available as single-dose vials or as the KwikPen, a ready-to-use pen with four weekly doses.
- Mounjaro is prescription-only in India. Actual pharmacy selling prices may be lower than the listed MRP.
What Is Mounjaro and How Does It Work?
Mounjaro is the brand name for tirzepatide, made by Eli Lilly and Company. It is a single injection under the skin, taken once every seven days.
It is approved in India for adults with type 2 diabetes, and for adults with obesity, or who are overweight with a weight-related health problem, in line with Lilly's approved indication for Mounjaro. It is always used alongside diet and physical activity, never in place of them.
Doctors call it a dual agonist, a medicine acting on two targets at once, because it copies two gut hormones, GLP-1 and GIP. Together they trigger insulin release when blood sugar is high, slow digestion so you feel full longer, and calm hunger signals in the brain. This is why tracking your HbA1c matters alongside weight when starting treatment.
What Is the Mounjaro Injection Price in India by Dose?
The table below shows the maximum retail price (MRP) for four weekly doses of each strength, as listed in September 2026. Actual pharmacy selling prices are sometimes lower than MRP, so treat these as ceiling figures rather than a fixed purchase price.
| Dose | Form | MRP for 4 Doses |
|---|---|---|
| 2.5 mg | 4 vials or 1 KwikPen | ₹13,125 |
| 5 mg | 4 vials or 1 KwikPen | ₹16,406 |
| 7.5 mg | 1 KwikPen, 4 doses | ₹20,625 |
| 10 mg | 1 KwikPen, 4 doses | ₹20,625 |
| 12.5 mg | 1 KwikPen, 4 doses | ₹25,781 |
| 15 mg | 1 KwikPen, 4 doses | ₹25,781 |
Notice that 7.5 mg and 10 mg cost the same, and so do 12.5 mg and 15 mg. This reflects the current listed MRP across major Indian pharmacies for these dose pairs.
A single 2.5 mg vial costs about ₹3,281 for one weekly dose. Not everyone needs the maximum dose, so starting low can mean a smaller bill for longer than expected.
Does the Vial or the KwikPen Cost Less?
The vial and KwikPen can cost about the same at the 2.5 mg and 5 mg strengths when you compare four weekly vials with one four-dose KwikPen. The main difference is convenience. Each vial contains one weekly dose, while the KwikPen is pre-filled and contains four weekly doses. Yurpeak is another tirzepatide brand distributed by Cipla in India, with broadly similar listed prices.
What Is the Real Monthly Budget, Not Just the Injection?
The injection is not the only expense. Doctor visits and blood tests add to the real first month cost, though later months are usually lighter once baseline tests are done.
| Cost Item | Starting Month | Ongoing Month |
|---|---|---|
| Mounjaro injection | About ₹13,125 | ₹20,625 to ₹25,781 |
| Doctor consultation | ₹500 to ₹2,000 | Every 1 to 3 months |
| Baseline blood tests (HbA1c, kidney) | ₹800 to ₹3,000 | Not needed monthly |
| Pen needles | ₹100 to ₹300 | ₹100 to ₹300 |
Illustrative estimates. Actual charges vary by city, doctor, and laboratory, so confirm current rates before budgeting.
How Does the Mounjaro Dose Increase Over Time?
The 2.5 mg dose is used as the starting dose to help your body adjust. The usual next dose is 5 mg after four weeks.
The prescribing information allows 2.5 mg steps, no sooner than every four weeks, up to a maximum of 15 mg. At the fastest allowed pace, reaching the top dose takes at least five months. Not everyone needs the maximum dose. Your doctor may keep you at a lower dose if it is working well and you are tolerating it.
Who Is Mounjaro For, and Who Should Avoid It?
Mounjaro is mainly for adults with type 2 diabetes, or adults who are overweight or obese with a weight-related health problem, according to the approved indication. Mounjaro is intended for adults with these approved conditions and should be used only under medical supervision.
Share your full medical history first. Avoid Mounjaro if you or a family member has had medullary thyroid carcinoma (a rare thyroid cancer), the endocrine condition MEN 2, or a serious tirzepatide allergy. It is not meant for type 1 diabetes. Use it only with close supervision if you have had pancreatitis, slowed stomach emptying, or kidney disease. See how Mounjaro compares with Ozempic if you are weighing options. It should not be used for weight management during pregnancy. If pregnant, planning pregnancy, or breastfeeding, discuss it with your doctor first.
What Does the Clinical Research Actually Show?
Across the SURPASS trials in people with type 2 diabetes, tirzepatide produced meaningful drops in HbA1c (a three month blood sugar average), though results varied by study, dose, and background treatment.
In the SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, adults with obesity on the 15 mg dose had an average weight reduction of about 20.9 percent at 72 weeks, alongside diet and activity changes. Not everyone lost this much weight, individual results varied. If your blood sugar sits in the prediabetes range, this is worth discussing with your doctor alongside your weight goals.
What Are the Side Effects of Mounjaro?
Most side effects are stomach related, especially in the first few weeks and after each dose increase, and they usually ease over time. Common ones include nausea, vomiting, loose motions, constipation, reduced appetite, and stomach discomfort.
Serious side effects are less common but need urgent care. These include pancreatitis (pancreas inflammation, causing severe pain that can spread to the back), gallbladder problems, low blood sugar when combined with insulin or sulfonylurea medicines, kidney problems from dehydration, and serious allergic reactions such as facial or throat swelling.
Mounjaro also carries a boxed warning about thyroid C-cell tumours, based on animal studies. Whether this risk applies to humans is not known. Tell your doctor promptly about any new neck lump, hoarse voice, or difficulty swallowing.
When to Get Emergency Help
- Severe stomach pain that will not settle, especially spreading to the back
- Trouble breathing, or swelling of the face, lips, or throat
- Yellow skin or eyes, high fever, or intense upper right belly pain
- Confusion, fainting, or very low blood sugar that does not improve
- A new neck lump, hoarse voice, or difficulty swallowing
If you use an oral contraceptive pill, tell your doctor before starting Mounjaro. Tirzepatide can affect how well oral hormonal contraceptives are absorbed, especially after starting treatment and after dose increases. Your doctor may advise a backup or non-oral contraceptive method.
Is Mounjaro Covered by Insurance in India?
Coverage depends heavily on your policy. Weight management medicines are often excluded from standard plans, while treatment for diagnosed diabetes may be handled differently under a diabetes rider. Keep your prescription and diagnosis records ready, and call your insurer before starting to confirm whether tirzepatide is covered.
How Does Mounjaro Compare With Semaglutide on Price?
Semaglutide (sold as Ozempic and Wegovy) became noticeably cheaper in India in 2026, after its Indian patent ended in March 2026 and several Indian companies launched generic versions. See our full semaglutide brands guide for a complete breakdown.
Tirzepatide, the active ingredient in Mounjaro, remains under patent in India, so no generic version is currently available. Generic availability can change as patents, regulatory approvals, and manufacturers change, so check the current Indian market rather than assuming a generic exists. Semaglutide may be cheaper today, but the two medicines are not interchangeable. Your doctor will weigh your goals, health, and budget to recommend the right one.
How Should You Store Mounjaro, and What If You Miss a Dose?
Keep an unused vial or KwikPen in the refrigerator between 2 and 8 degrees Celsius until first use. Once a KwikPen is used for the first time, Lilly's official storage guidance allows it to stay at room temperature, below 30 degrees Celsius, for up to 30 days before it must be discarded, even with medicine left inside. This 30 day in-use rule applies to the KwikPen specifically, not to an unopened vial. Never freeze either form, and check the liquid looks clear before injecting.
If you miss a dose and it has been 4 days or less, take it as soon as you remember, then return to your normal weekly day. Beyond 4 days, skip that dose and resume on schedule. Never take two doses within 3 days of each other, even to catch up.
Doctor's Tip
A weekly phone reminder can help you remember your injection and keep your doses on schedule.
Plan for at least three to six months of treatment, since the dose usually rises gradually. Buy only with a valid prescription from a licensed pharmacy, and check the pack is sealed before accepting it. The World Health Organization has warned about falsified GLP-1 products as demand has grown, so verify the cold chain if ordering online.
Key Takeaways
- Confirm your exact dose with your doctor first. It is the single biggest factor in your monthly bill.
- Ask your pharmacy to compare vial and KwikPen pricing for your specific dose before buying.
- Call your insurer directly to check coverage rather than assuming your plan excludes it.
- Store an in-use KwikPen at room temperature for no more than 30 days, and never use it if it has been frozen.
- Budget for ongoing treatment, because your cost can change if your dose increases.
Frequently Asked Questions
What is the Mounjaro injection price in India in 2026?
It ranges from about ₹13,125 to ₹25,781 for four weekly doses, depending mainly on the prescribed strength and current pharmacy price.
How much does the 2.5 mg Mounjaro injection cost?
A single 2.5 mg vial costs about ₹3,281 per week, or roughly ₹13,125 for a full month of four doses.
Is Mounjaro used for weight loss in India?
Yes, for both type 2 diabetes and weight management in adults, always alongside diet and activity, and only with a prescription.
Why does the price go up with each dose?
Higher doses contain more active medicine, so they cost more. Since treatment usually starts at a lower dose, the medicine may cost less during the early months if your dose remains low.
How long does it take to reach the highest dose?
At the minimum four week interval, reaching 15 mg takes at least five months. Not everyone needs the maximum dose. Your doctor may keep you at a lower dose if it is working well and you are tolerating it.
What should I do if I miss a dose?
Take it within 4 days of the missed day. Beyond that, skip it and resume next week. Never take two doses within 3 days of each other.
How long can Mounjaro stay out of the fridge?
Once in use, a KwikPen can stay at room temperature, below 30 degrees Celsius, for up to 30 days. After that it must be discarded, even with medicine remaining.
Who should not take Mounjaro?
Avoid it if you or a family member has had medullary thyroid carcinoma, MEN 2, or a serious tirzepatide allergy. It is not recommended in pregnancy, and a history of pancreatitis needs close supervision.
Can I buy Mounjaro without a prescription in India?
No. It is a prescription only medicine in India and can only be sold by licensed pharmacies.
Is there a cheaper generic alternative available?
Not for tirzepatide itself, since it remains under patent. Generic availability can change as patents, regulatory approvals, and manufacturers change, so check the current Indian market before assuming a generic exists. Semaglutide, a related but different medicine, became cheaper in India in 2026 after its own patent expired.
References and Sources
- World Health Organization. Diabetes: key facts, 2024.
- ICMR-INDIAB Study, The Lancet Diabetes and Endocrinology, 2023.
- New England Journal of Medicine. Tirzepatide Once Weekly for the Treatment of Obesity, SURMOUNT-1, 2022.
- U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information, via DailyMed.
- Eli Lilly and Company. Mounjaro KwikPen storage guidance.
- World Health Organization. Statement on falsified GLP-1 medicines, 2024.
- Mayo Clinic. Tirzepatide: uses, dosing, and side effects.
Written by
Iraphan Khan, BSN, RN, D.Pharm, Public Health Researcher
Founder of RealMedVision, writing patient-focused health content based on clinical guidelines and peer-reviewed research.
Medically reviewed by
Dr Praveen Verma, MBBS, MD (Pathology), Pathologist and Clinical Laboratory Specialist
Dr Himanshu Morya, MBBS, Medical Educator
This article is for information and education only, and is not a substitute for professional medical advice. Prices are approximate for September 2026 and can change by pharmacy, city, and pack. Mounjaro is a prescription medicine. Always talk to your doctor before starting, stopping, or changing any treatment.